These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3088272)
1. Oral contraception, 1986. Currently available formulations. Hale R J Reprod Med; 1986 Jun; 31(6 Suppl):557-8. PubMed ID: 3088272 [TBL] [Abstract][Full Text] [Related]
2. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. Christie T J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701 [No Abstract] [Full Text] [Related]
4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
5. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives. Johansson ED; Elamsson K; Elmestedt U Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379 [No Abstract] [Full Text] [Related]
6. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America. Moggia AV J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704 [TBL] [Abstract][Full Text] [Related]
7. The 150/30 formulation. Experience in the United Kingdom. Guillebaud J J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702 [TBL] [Abstract][Full Text] [Related]
8. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect]. Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064 [No Abstract] [Full Text] [Related]
10. Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins. Taggart H; Stout RW Ir J Med Sci; 1981 Jan; 150(1):13-4. PubMed ID: 7216711 [No Abstract] [Full Text] [Related]
11. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
12. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm]. Milchev N; Terzhumanov R; Grozdanov G; Krumov G Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561 [No Abstract] [Full Text] [Related]
13. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [TBL] [Abstract][Full Text] [Related]